- Home
- JBIO vs HBB Comparison
JBIO vs HBB Comparison
Compare JBIO & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBIO
- HBB
- Stock Information
- Founded
- JBIO 2024
- HBB 1904
- Country
- JBIO United States
- HBB United States
- Employees
- JBIO N/A
- HBB N/A
- Industry
- JBIO
- HBB Home Furnishings
- Sector
- JBIO
- HBB Consumer Discretionary
- Exchange
- JBIO NYSE
- HBB Nasdaq
- Market Cap
- JBIO 290.1M
- HBB 242.8M
- IPO Year
- JBIO N/A
- HBB 2017
- Fundamental
- Price
- JBIO $8.28
- HBB $18.31
- Analyst Decision
- JBIO Strong Buy
- HBB
- Analyst Count
- JBIO 2
- HBB 0
- Target Price
- JBIO $15.50
- HBB N/A
- AVG Volume (30 Days)
- JBIO 397.1K
- HBB 35.8K
- Earning Date
- JBIO 08-05-2025
- HBB 07-30-2025
- Dividend Yield
- JBIO N/A
- HBB 2.75%
- EPS Growth
- JBIO N/A
- HBB 18.18
- EPS
- JBIO N/A
- HBB 2.43
- Revenue
- JBIO N/A
- HBB $659,788,000.00
- Revenue This Year
- JBIO N/A
- HBB N/A
- Revenue Next Year
- JBIO N/A
- HBB N/A
- P/E Ratio
- JBIO N/A
- HBB $7.21
- Revenue Growth
- JBIO N/A
- HBB 5.46
- 52 Week Low
- JBIO $1.61
- HBB $13.25
- 52 Week High
- JBIO $13.50
- HBB $31.78
- Technical
- Relative Strength Index (RSI)
- JBIO N/A
- HBB 50.82
- Support Level
- JBIO N/A
- HBB $17.50
- Resistance Level
- JBIO N/A
- HBB $18.50
- Average True Range (ATR)
- JBIO 0.00
- HBB 0.88
- MACD
- JBIO 0.00
- HBB -0.14
- Stochastic Oscillator
- JBIO 0.00
- HBB 33.77
About JBIO JADE BIOSCIENCES INC
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.